PMID- 34880869 OWN - NLM STAT- MEDLINE DCOM- 20220210 LR - 20220210 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 12 DP - 2021 TI - Conditioned Medium of Human Amniotic Epithelial Cells Alleviates Experimental Allergic Conjunctivitis Mainly by IL-1ra and IL-10. PG - 774601 LID - 10.3389/fimmu.2021.774601 [doi] LID - 774601 AB - Allergic conjunctivitis (AC) is the most prevalent form of mucosal allergy, and the conditioned medium (CM) from mesenchymal stem cells has been reported to attenuate some allergic diseases. However, the therapeutic effects of CM from different tissue stem cells (TSC-CM) on allergic diseases have not been tested. Here, we studied the effects of topical administration of different human TSC-CM on experimental AC (EAC) mice. Only human amniotic epithelial cell-CM (AECM) significantly attenuated allergic eye symptoms and reduced the infiltration of immune cells and the levels of local inflammatory factors in the conjunctiva compared to EAC mice. In addition, AECM treatment decreased immunoglobulin E (IgE) release, histamine production, and the hyperpermeability of conjunctival vessels. Protein chip assays revealed that the levels of anti-inflammatory factors, interleukin-1 receptor antagonist (IL-1ra) and IL-10, were higher in AECM compared to other TSC-CM. Furthermore, the anti-allergic effects of AECM on EAC mice were abrogated when neutralized with IL-1ra or IL-10 antibody, and the similar phenomenon was for the activation and function of B cells and mast cells. Together, the present study demonstrated that AECM alleviates EAC symptoms by multiple anti-allergic mechanisms mainly via IL-1ra and IL-10. Such topical AECM therapy may represent a novel and feasible strategy for treating AC. CI - Copyright (c) 2021 Wu, Gao, Lin, Lu, Xu and Xu. FAU - Wu, Binxin AU - Wu B AD - Department of Ophthalmology of Shanghai Tenth People's Hospital, Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China. FAU - Gao, Furong AU - Gao F AD - Department of Ophthalmology of Shanghai Tenth People's Hospital, Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China. FAU - Lin, Jianhua AU - Lin J AD - Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. FAU - Lu, Lixia AU - Lu L AD - Department of Ophthalmology of Shanghai Tenth People's Hospital, Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China. FAU - Xu, Huiming AU - Xu H AD - State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. FAU - Xu, Guo-Tong AU - Xu GT AD - Department of Ophthalmology of Shanghai Tenth People's Hospital, Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China. AD - Department of Pharmacology, Tongji University School of Medicine, Shanghai, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211122 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Culture Media, Conditioned) RN - 0 (Cytokines) RN - 0 (Interleukin-1alpha) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Adipogenesis MH - Amnion/*cytology MH - Animals MH - B-Lymphocytes/immunology/metabolism MH - Capillary Permeability MH - Cells, Cultured MH - Conjunctivitis, Allergic/diagnosis/*etiology/*metabolism MH - Culture Media, Conditioned/*pharmacology MH - Cytokines/metabolism MH - Disease Models, Animal MH - Disease Susceptibility MH - Epithelial Cells/*metabolism MH - Female MH - Humans MH - Immunohistochemistry MH - Interleukin-10/*metabolism MH - Interleukin-1alpha/*metabolism MH - Mice MH - Osteogenesis MH - Pregnancy PMC - PMC8645696 OTO - NOTNLM OT - AECM OT - EAC OT - IL-10 OT - IL-1ra OT - tissue stem cells COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/12/10 06:00 MHDA- 2022/02/11 06:00 PMCR- 2021/01/01 CRDT- 2021/12/09 07:00 PHST- 2021/09/12 00:00 [received] PHST- 2021/10/25 00:00 [accepted] PHST- 2021/12/09 07:00 [entrez] PHST- 2021/12/10 06:00 [pubmed] PHST- 2022/02/11 06:00 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2021.774601 [doi] PST - epublish SO - Front Immunol. 2021 Nov 22;12:774601. doi: 10.3389/fimmu.2021.774601. eCollection 2021.